Tai Ying-Hsuan, Chang Ming-Long, Chu Pao-Hsien, Yeh Chun-Chieh, Cherng Yih-Giun, Chen Ta-Liang, Liao Chien-Chang
Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.
Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
J Clin Med. 2022 Feb 28;11(5):1341. doi: 10.3390/jcm11051341.
Gastroenteritis promotes the development of systemic inflammation and a hypercoagulable state. There are limited data regarding the association between gastroenteritis and acute myocardial infarction (AMI). We aimed to evaluate the risk of AMI after an episode of gastroenteritis. In this nested case-control study, we selected patients who were hospitalized for AMI ( = 103,584) as a case group during 2010-2017 and performed propensity score matching (case-control ratio 1:1) to select eligible controls from insurance research data in Taiwan. We applied multivariable logistic regressions to calculate adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for the risk of AMI associated with recent gastroenteritis within 14 days before AMI. We also compared the outcomes after AMI in patients with or without gastroenteritis. A total of 1381 patients (1.3%) with AMI had a prior episode of gastroenteritis compared to 829 (0.8%) among the controls. Gastroenteritis was significantly associated with a subsequent risk of AMI (adjusted OR: 1.68, 95% CI: 1.54-1.83), which was augmented in hospitalizations for gastroenteritis (adjusted OR: 2.50, 95% CI: 1.20-5.21). The outcomes after AMI were worse in patients with gastroenteritis than in those without gastroenteritis, including increased 30-day in-hospital mortality (adjusted OR: 1.28, 95% CI: 1.08-1.52), medical expenditure, and length of hospital stay. Gastroenteritis may act as a trigger for AMI and correlates with worse post-AMI outcomes. Strategies of aggressive hydration and/or increased antithrombotic therapies for this susceptible population should be further developed.
肠胃炎会促进全身炎症的发展以及高凝状态。关于肠胃炎与急性心肌梗死(AMI)之间关联的数据有限。我们旨在评估肠胃炎发作后发生AMI的风险。在这项巢式病例对照研究中,我们选取了2010年至2017年期间因AMI住院的患者(n = 103,584)作为病例组,并进行倾向评分匹配(病例对照比为1:1),以从台湾的保险研究数据中选取符合条件的对照组。我们应用多变量逻辑回归来计算与AMI前14天内近期肠胃炎相关的AMI风险的调整优势比(OR)及95%置信区间(CI)。我们还比较了有或无肠胃炎的患者发生AMI后的结局。共有1381例(1.3%)AMI患者有过肠胃炎发作史,而对照组中有829例(0.8%)。肠胃炎与随后发生AMI的风险显著相关(调整后OR:1.68,95%CI:1.54 - 1.83),在因肠胃炎住院的患者中这种相关性增强(调整后OR:2.50,95%CI:1.20 - 5.21)。有肠胃炎的患者发生AMI后的结局比无肠胃炎的患者更差,包括30天院内死亡率增加(调整后OR:1.28,95%CI:1.08 - 1.52)、医疗费用增加以及住院时间延长。肠胃炎可能是AMI的触发因素,并与AMI后更差的结局相关。对于这一易感人群,应进一步制定积极补液和/或增加抗栓治疗的策略。